Anaspec, Inc.
- UEI
- D8RQMATPY3E1
- CAGE
- 068E9
- Primary NAICS
- 325199 All Other Basic Organic Chemical Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- anaspec.com
- Founded
- 1993
- Employees
- 51-250
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $15,827 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| JPT Peptide Technologies GMBH | Berlin, BE | 325414 Biological Product (except Diagnostic) Manufacturing |
| Peptide 2.0 Inc. | Chantilly, VA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Genemed Synthesis, Inc. | San Antonio, TX | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Echelon Biosciences Inc. | Salt Lake City, UT | 334516 Analytical Laboratory Instrument Manufacturing |
| Polypeptide Labs | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Anaspec, Inc. is a manufacturer of peptides, glycoproteins, and related biochemical products and services for the life sciences industry and government agencies. According to its website, Anaspec is a leading biotechnology company and contract manufacturing organization based in the United States that serves academia, biopharmaceutical firms, and diagnostic companies.
Through prime federal contract awards, Anaspec, Inc. has provided various peptides, glycoproteins, antimicrobial peptides, protein biochemistry services, and related products to the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research as well as the Department of Agriculture, Agricultural Research Service. These contracts were competed without being set aside for specific socioeconomic programs. The products and services supported research efforts at the funding agencies in areas such as protein biochemistry related to MUC5AC and antimicrobial peptide development. Contract values ranged from approximately $10,000 to $63,000, with completion dates spanning 2020 to 2023.
Quick answers
Is Anaspec, Inc. registered in SAM.gov?
Anaspec, Inc.'s SAM.gov registration expired on March 2, 2023.
What is Anaspec, Inc.'s CAGE code?
Anaspec, Inc.'s CAGE code is 068E9, and its Unique Entity ID (UEI) is D8RQMATPY3E1.
How much has Anaspec, Inc. received in federal contracts?
Federal contracts obligated $15,827 to Anaspec, Inc. in fiscal years 2023 through 2027.
What is Anaspec, Inc.'s most recent federal award?
Anaspec, Inc.'s most recent federal contract award is Peptides and glycopeptides (75N92C23P00007), from National Institute of Dental and Craniofacial Research (NIH), on January 25, 2023.
On GovTribe
See Anaspec, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors